Center for Industrial and Medical Ultrasound, Applied Physics Laboratory, University of Washington, Seattle, Washington, USA.
Department of Urology, University of Washington School of Medicine, Seattle, Washington, USA.
Ultrasound Med Biol. 2022 Sep;48(9):1762-1777. doi: 10.1016/j.ultrasmedbio.2022.05.002. Epub 2022 Jun 10.
Tissue-mimicking gels provide a cost-effective medium to optimize histotripsy treatment parameters with immediate feedback. Agarose and polyacrylamide gels are often used to evaluate treatment outcomes as they mimic the acoustic properties and stiffness of a variety of soft tissues, but they do not exhibit high toughness, a characteristic of fibrous connective tissue. To mimic pathologic fibrous tissue found in benign prostate hyperplasia (BPH) and other diseases that are potentially treatable with histotripsy, an optically transparent hydrogel with high toughness was developed that is a hybrid of polyacrylamide and alginate. The stiffness was established using shear wave elastography (SWE) and indentometry techniques and was found to be representative of human BPH ex vivo prostate tissue. Different phantom compositions and excised ex vivo BPH tissue samples were treated with a 700-kHz histotripsy transducer at different pulse repetition frequencies. Post-treatment, the hybrid gels and the tissue samples exhibited differential reduction in stiffness as measured by SWE. On B-mode ultrasound, partially treated areas were present as hyperechoic zones and fully liquified areas as hypoechoic zones. Phase contrast microscopy of the gel samples revealed liquefaction in regions consistent with the target lesion dimensions and correlated to findings identified in tissue samples via histology. The dose required to achieve liquefaction in the hybrid gel was similar to what has been observed in ex vivo tissue and greater than that of agarose of comparable or higher Young's modulus by a factor >10. These results indicate that the developed hydrogels closely mimic elasticities found in BPH prostate ex vivo tissue and have a similar response to histotripsy treatment, thus making them a useful cost-effective alternative for developing and evaluating different treatment protocols.
组织模拟凝胶提供了一种具有成本效益的介质,可以优化 histotripsy 治疗参数,并提供即时反馈。琼脂糖和聚丙烯酰胺凝胶常用于评估治疗效果,因为它们模拟了各种软组织的声特性和刚度,但它们不具有高韧性,这是纤维结缔组织的特征。为了模拟良性前列腺增生(BPH)和其他可能通过 histotripsy 治疗的疾病中发现的病理性纤维组织,开发了一种具有高韧性的光透明水凝胶,它是聚丙烯酰胺和海藻酸盐的混合物。使用剪切波弹性成像(SWE)和压痕技术确定了刚度,并发现其与人体 BPH 离体前列腺组织具有代表性。使用 700kHz histotripsy 换能器以不同的脉冲重复频率处理不同的模拟物组成和切除的离体 BPH 组织样本。治疗后,通过 SWE 测量,混合凝胶和组织样本的刚度表现出不同程度的降低。在 B 模式超声上,部分治疗区域表现为高回声区,完全液化区域表现为低回声区。凝胶样本的相差显微镜观察显示,在与目标病变尺寸一致的区域发生了液化,并与通过组织学在组织样本中发现的结果相关。在混合凝胶中实现液化所需的剂量与在离体组织中观察到的剂量相似,并且大于具有可比或更高杨氏模量的琼脂糖的剂量,相差 10 倍以上。这些结果表明,所开发的水凝胶紧密模拟了 BPH 前列腺离体组织中的弹性,并对 histotripsy 治疗有类似的反应,因此成为开发和评估不同治疗方案的一种具有成本效益的替代方法。